Veracyte Inc (NASDAQ: VCYT) flaunted slowness of -5.74% at $39.87, as the Stock market unbolted on Thursday, before settling in for the price of $42.3 at the close. Taking a more long-term approach, VCYT posted a 52-week range of $22.61-$47.32.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 424.68%. This publicly-traded company’s shares outstanding now amounts to $79.03 million, simultaneously with a float of $77.36 million. The organization now has a market capitalization sitting at $3.15 billion. At the time of writing, stock’s 50-day Moving Average stood at $35.48, while the 200-day Moving Average is $31.69.
Veracyte Inc (VCYT) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Veracyte Inc industry. Veracyte Inc’s current insider ownership accounts for 2.22%, in contrast to 119.09% institutional ownership. According to the most recent insider trade that took place on Nov 07 ’25, this organization’s VP, Chief Accounting Officer sold 5,818 shares at the rate of 40.21, making the entire transaction reach 233,929 in total value, affecting insider ownership by 43,847. Preceding that transaction, on Nov 10 ’25, Company’s VP, Chief Accounting Officer sold 5,102 for 42.33, making the whole transaction’s value amount to 215,978. This particular insider is now the holder of 38,745 in total.
Veracyte Inc (VCYT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.34 per share during the current fiscal year. Veracyte Inc’s EPS increase for this current 12-month fiscal period is 424.68% and is forecasted to reach 1.59 in the upcoming year.
Veracyte Inc (NASDAQ: VCYT) Trading Performance Indicators
Let’s observe the current performance indicators for Veracyte Inc (VCYT). It’s Quick Ratio in the last reported quarter now stands at 5.94. Alongside those numbers, its PE Ratio stands at $105.00, and its Beta score is 1.84. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.37. Similarly, its price to free cash flow for trailing twelve months is now 32.09.
In the same vein, VCYT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.38, a figure that is expected to reach 0.39 in the next quarter, and analysts are predicting that it will be 1.59 at the market close of one year from today.
Technical Analysis of Veracyte Inc (VCYT)
Now, what If we examine the latest scores posted by [Veracyte Inc, VCYT]. During the last 5-days, its volume was lower the volume of 1.11 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 57.01% While, its Average True Range was 52.68.
Raw Stochastic average of Veracyte Inc (VCYT) in the period of the previous 100 days is set at 72.43%, which indicates a major rise in contrast to 43.34% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.08 that was higher than 1.29 volatility it exhibited in the past 100-days period.
